Love W. Ted's Insider Trades & SAST Disclosures
Love W. Ted's most recent trade in Royalty Pharma plc - Ordinary Shares - Class A was a trade of 7,614 Class A Ordinary Shares done . Disclosure was reported to the exchange on May 13, 2025.
Add Superstar Alert
Share
Note
This is a custom search result for pattern Love W. Ted.To see full superstar portfolios of large investors like Warren Buffet, Elon Musk and others, click here.
Advanced/Help
"Balanced Fund": Use this format with quotation marks to find the exact phrase. The output matches
"Balanced Fund"
but not "Balanced Growth Fund"
Balanced Fund: Use this format without quotation marks to search for all funds related to the term
"Balanced Fund" The results may include
"Balanced Income Fund", "Balanced Growth Fund" and any fund name containing "Balanced Fund".
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Royalty Pharma plc - Ordin... | Ted W. Love | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 May 2025 | 7,614 | 53,848 | - | 0 | Class A Ordinary Shares | |
| Gilead Sciences, Inc. | Ted W. Love | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 07 May 2025 | 6,809 | 6,809 | - | - | Non-qualified Stock Option (Right to Buy) | |
| Gilead Sciences, Inc. | Ted W. Love | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 07 May 2025 | 1,516 | 4,338 (0%) | 0% | 0 | Common Stock | |
| Structure Therapeutics Inc... | Ted W. Love | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 Jun 2024 | 33,595 | 33,595 | - | - | Share Option (right to buy) | |
| Royalty Pharma plc - Ordin... | Ted W. Love | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 07 Jun 2024 | 9,293 | 46,234 | - | 0 | Class A Ordinary Shares | |
| Gilead Sciences, Inc. | Ted W. Love | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 May 2024 | 12,648 | 12,648 | - | - | Non-qualified Stock Option (Right to Buy) | |
| Gilead Sciences, Inc. | Ted W. Love | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 May 2024 | 2,310 | 2,822 (0%) | 0% | 0 | Common Stock | |
| Gilead Sciences, Inc. | Ted W. Love | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Feb 2024 | 2,996 | 2,996 | - | - | Non-qualified Stock Option (Right to Buy) | |
| Gilead Sciences, Inc. | Love W. Ted | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Feb 2024 | 512 | 512 (0%) | 0% | 0 | Common Stock | |
| Royalty Pharma plc - Ordin... | Ted W. Love | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 Jun 2023 | 7,747 | 36,941 | - | 0 | Class A Ordinary Shares | |
| Seagen Inc | Ted W. Love | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 May 2023 | 2,044 | 6,748 (0%) | 0% | 0 | Common Stock | |
| Royalty Pharma plc - Ordin... | Ted W. Love | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 24 Jun 2022 | 6,328 | 29,194 | - | 0 | Class A Ordinary Shares | |
| Seagen Inc | Ted W. Love | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 May 2022 | 3,676 | 3,676 | - | - | Non-Qualified Stock Option (right to buy) | |
| Seagen Inc | Ted W. Love | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 May 2022 | 1,503 | 4,704 (0%) | 0% | 0 | Common Stock | |
| Royalty Pharma plc - Ordin... | Ted W. Love | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 Jun 2021 | 5,726 | 22,866 | - | 0 | Class A Ordinary Shares | |
| Seagen Inc | Ted W. Love | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 May 2021 | 3,462 | 3,462 | - | - | Non-Qualified Stock Option (right to buy) | |
| Seagen Inc | Ted W. Love | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 May 2021 | 1,402 | 3,201 (0%) | 0% | 0 | Common Stock | |
| Seagen Inc | Ted W. Love | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Aug 2020 | 4,460 | 4,460 | - | - | Non-Qualified Stock Option (right to buy) | |
| Seagen Inc | Ted W. Love | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Aug 2020 | 1,799 | 1,799 (0%) | 0% | 0 | Common Stock | |
| Royalty Pharma plc - Ordin... | Ted W. Love | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 Aug 2020 | 7,280 | 17,280 | - | 0 | Class A Ordinary Shares |
*All Values are in $ Million
Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc
Security Type: Share/ Warrants / Convertible Debentures
Security Type: Share/ Warrants / Convertible Debentures
Data as reported to USA Exchanges